Ladiratuzumab
Product Specifications
CAS Number
1629760-28-6
Target
Others|||ADC Antibody
Related Pathways
Antibody-drug Conjugate/ADC Related|||Others
Purity
0.982
Bioactivity
LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.LadiratuzumAb can be used for the prevention and treatment of breast cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
044055-ML405 100 µL
ZEB2, CT (ZEB2, KIAA0569, SIP1, ZFHX1B, ZFX1B, Zinc finger E-box-binding homeobox 2, Smad-interacting protein 1, Zinc finger homeobox protein 1b) (MaxLight 405) discontinued
Ask
View Details ![Rabbit Polyclonal Hepatitis E Virus Antibody [DyLight 650]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
GTR15270865 1 Vial
Lentiviral mouse Ajap1 shRNA (UAS) - Lentiviral mouse Ajap1 shRNA (UAS, RFP) plasmid
Ask
View Details 
38666121 3x 1.0µg DNA
RBMXP1 CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details 034140-ML750 100 µL
COX5B, ID (COX5B, Cytochrome c oxidase subunit 5B, mitochondrial, Cytochrome c oxidase polypeptide Vb) (MaxLight 750) discontinued
Ask
View Details